Related references
Note: Only part of the references are listed.NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress
Qian Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity
K. Hashimoto
PSYCHOLOGICAL MEDICINE (2016)
NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism
Carly Kiselycznyk et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders
Y. Ohgi et al.
CURRENT MOLECULAR MEDICINE (2015)
Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression
Ji-chun Zhang et al.
PSYCHOPHARMACOLOGY (2015)
Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests
Arya Haj-Mirzaian et al.
PSYCHOPHARMACOLOGY (2015)
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
C. Yang et al.
TRANSLATIONAL PSYCHIATRY (2015)
The Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition
Panos Zanos et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Glutamate Receptor Antagonists as Fast-Acting Therapeutic Alternatives for the Treatment of Depression: Ketamine and Other Compounds
Mark J. Niciu et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
R(-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
Ji-chun Zhang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
GluN2B-Containing NMDA Receptors Regulate Depression-Like Behavior and are Critical for the Rapid Antidepressant Actions of Ketamine
Oliver H. Miller et al.
ELIFE (2014)
The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
Kenji Hashimoto
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2014)
Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice
Xian-Cang Ma et al.
PLOS ONE (2013)
Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
Kenji Hashimoto
PROGRESS IN NEUROBIOLOGY (2013)
Roles of glutamate signaling in preclinical and/or mechanistic models of depression
Kenichi Tokita et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Emerging role of glutamate in the pathophysiology of major depressive disorder
Kenji Hashimoto
BRAIN RESEARCH REVIEWS (2009)
Glutamate-based antidepressants: 20 years on
Phil Skolnick et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Share Paper
